| Abbreviation | Full Name |
| A20 | Tumor Necrosis Factor Alpha-Induced Protein 3 |
| BC | Breast Cancer |
| CI | Confidence Interval |
| CNS | Central Nervous System |
| CSC | Cancer Stem Cells |
| DAPI | 4′,6-Diamidino-2-Phenylindole |
| DFS | Disease-Free Survival |
| EMT | Epithelial–Mesenchymal Transition |
| ER | Estrogen Receptor |
| FA | Fibroadenoma |
| FFPE | Formalin-Fixed Paraffin-Embedded |
| FOXP3+ | Forkhead Box P3–Positive |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| HSP70 | Heat Shock Protein 70 |
| HR | Hazard Ratio |
| IgG1 | Immunoglobulin G1 |
| IHC | Immunohistochemistry |
| Ki-67 | Ki-67 Proliferation Index |
| MDSC | Myeloid-Derived Suppressor Cells |
| MMP | Matrix Metalloproteinase |
| MT | Metallothionein |
| NF-κB | Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells |
| NST | No Special Type |
| Nrf2 | Nuclear Factor Erythroid 2–Related Factor 2 |
| OS | Overall Survival |
| PD-L1 | Programmed Death-Ligand 1 |
| PH | Proportional Hazards |
| PR | Progesterone Receptor |
| rhHSP70 | Recombinant Human Heat Shock Protein 70 |
| ROS | Reactive Oxygen Species |
| SE | Standard Error |
| TMA | Tissue Microarray |
| TNBC | Triple-Negative Breast Cancer |
| TNM | Tumor–Node–Metastasis |